Publication Date
6-3-2024
Journal
Scientific Reports
DOI
10.1038/s41598-024-63468-z
PMID
38831004
PMCID
PMC11148192
Published Open-Access
no
Keywords
Humans, Lung Neoplasms, Mutation, Selection, Genetic, Biomarkers, Tumor, Mutation, Missense, Carcinoma, Squamous Cell, Cancer, Evolution
Abstract
Single nucleotide substitutions are the most common type of somatic mutations in cancer genome. The goal of this study was to use publicly available somatic mutation data to quantify negative and positive selection in individual lung tumors and test how strength of directional and absolute selection is associated with clinical features. The analysis found a significant variation in strength of selection (both negative and positive) among tumors, with median selection tending to be negative even though tumors with strong positive selection also exist. Strength of selection estimated as the density of missense mutations relative to the density of silent mutations showed only a weak correlation with tumor mutation burden. In the "all histology together" analysis we found that absolute strength of selection was strongly correlated with all clinically relevant features analyzed. In histology-stratified analysis selection was strongest in small cell lung cancer. Selection in adenocarcinoma was somewhat higher compared to squamous cell carcinoma. The study suggests that somatic mutation- based quantifying of directional and absolute selection in individual tumors can be a useful biomarker of tumor aggressiveness.
Comments
Associated Data